Ashton Thomas Private Wealth, LLC Halozyme Therapeutics, Inc. Transaction History
Ashton Thomas Private Wealth, LLC
- $2.84 Trillion
- Q2 2025
A detailed history of Ashton Thomas Private Wealth, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 6,864 shares of HALO stock, worth $447,532. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,864
Previous 4,170
64.6%
Holding current value
$447,532
Previous $266 Million
34.19%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding HALO
# of Institutions
606Shares Held
127MCall Options Held
408KPut Options Held
388K-
Black Rock Inc. New York, NY17.6MShares$1.15 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$798 Million0.01% of portfolio
-
State Street Corp Boston, MA5.94MShares$387 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.47MShares$226 Million0.03% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.4MShares$222 Million3.92% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $9.08B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...